Clinical Investigation (MHS-CI) Track

The Master of Health Science in Clinical Investigation (MHS-CI) program is dedicated to training the next generation of multidisciplinary clinicians, physician-scientists, and researchers in clinical investigation. The program emphasizes the importance of translating and reverse-translating research findings to address critical health issues and optimize patient care. A key aspect of the program is fostering strong mentor-mentee relationships and promoting collaboration between scientists and clinicians. The program actively encourages female and underrepresented individuals to pursue careers in clinical investigation and translational research.

Students in the MHS-CI program will develop a range of essential skills, including in-depth research methodology, hypothesis-driven research projects, clinical science, molecular genomic pathology in precision medicine, and pragmatic trial design and implementation. Additionally, the program focuses on building leadership skills that will enable graduates to excel in their careers and make meaningful contributions to the field of clinical investigation. The program spans two academic years, including two summers, and requires a minimum of 30 credits for completion.

A significant component of the MHS-CI program is the thesis research project. Each student is required to complete this project and submit a master’s thesis document before graduation. The thesis committee, composed of three faculty members, provides oversight, with the primary advisor offering broad clinical and translational guidance.

Upon entry into the MHS-CI program, each student works with the MHS-CI leadership and their thesis committee to design an Individual Learning Plan (ILP). The ILP is tailored to the student’s background, research interests, career goals, and the guidance of their mentor. This plan is a dynamic process, involving continuous evaluation and updates as needed. The ILP identifies a research project, establishes a laboratory or clinical environment, sets expectations and timelines, and provides guidance to help the student achieve their professional goals. The students are required to meet with their thesis committee semiannually to discuss their ILP.

The MHS-CI program is committed to producing graduates who are well-equipped to drive advancements in biomedical research and enhance patient care. Through rigorous academic and professional standards, the program aims to cultivate a diverse and dynamic learning environment that supports innovative research and meaningful contributions to the field of clinical investigation.